FCF Grants Awarded in 2019

Total grants: 5

• Retinoic acid-induced loss of DNAJB1-PRKACA fusion protein expression — Principal investigator(s): Andrew Yen, Praveen Sethupathy — Cornell University
• A Pilot Study of a DNAJB1-PRKACA fusion kinase vaccine combined with nivolumab and ipilimumab for patients with fibrolamellar carcinoma (FLC) — Principal investigator(s): Mark Yarchoan — Johns Hopkins University
• Molecular therapies for fibrolamellar carcinoma (FLC) — Principal investigator(s): John Scott — University of Washington
• Targeting DNAJB1-PRKACA driven signaling dependencies in FLC — Principal investigator(s): John Gordan, Nabeel Bardeesy — University of California at San Francisco, Massachusetts General Hospital
• Development of a human-derived liver progenitor cell line with DNAJB1-PRKACA fusion gene — Principal investigator(s): Khashayar Vakili — Boston Children’s Hospital

This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded in 2019. The name of the grant is listed, along with the institution receiving the grant and the principal investigator.